Literature DB >> 20494662

Comparison of frequency of inducible myocardial ischemia in patients presenting to emergency department with typical versus atypical or nonanginal chest pain.

Luke K Hermann1, Scott D Weingart, Yong M Yoon, Nicholas G Genes, Bret P Nelson, Peter L Shearer, W Lane Duvall, Milena J Henzlova.   

Abstract

The present study was designed to assess the value of the presenting symptom of "typical" anginal pain, "atypical/nonanginal" pain, or the lack of chest pain in predicting the presence of inducible myocardial ischemia using cardiac stress testing in emergency department patients being evaluated for possible acute coronary syndrome. We performed a retrospective observational study of adult patients who were evaluated for acute coronary syndrome in an emergency department chest pain unit. The presenting symptoms were obtained from a structured questionnaire administered before stress testing. Patient chest pain was categorized according to the presence of substernal chest pain or discomfort that was provoked by exertion or emotional stress and was relieved by rest and/or nitroglycerin. Chest pain was classified as "typical" angina if all 3 descriptors were present and "atypical" or "nonanginal" if <3 descriptors were present. All patients underwent serial biomarker and cardiac stress testing before discharge. A total of 2,525 patients met the eligibility criteria. Inducible ischemia on stress testing was found in 33 (14%, 95% confidence interval 10% to 19%) of the 231 patients who had typical anginal pain, 238 (11%, 95% confidence interval 10% to 13%) of the 2,140 patients presenting with atypical/nonanginal chest pain, and 25 (16%, 95% confidence interval 11% to 22%) of the 153 patients who had no complaint of chest pain on presentation. Compared to patients with atypical or no chest pain, patients with typical chest pain were not significantly more likely to have inducible ischemia on stress testing (likelihood ratio +1.25, 95% confidence interval 0.89 to 1.78). In conclusion, in our study, the patients who presented with "typical" angina were no more likely to have inducible myocardial ischemia on stress testing than patients with other presenting symptoms. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20494662     DOI: 10.1016/j.amjcard.2010.01.014

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Management and outcomes of patients with unstable angina with undetectable, normal, or intermediate hsTnT levels.

Authors:  Evangelos Giannitsis; Moritz Biener; Hauke Hund; Matthias Mueller-Hennessen; Mehrshad Vafaie; Jochen Gandowitz; Christoph Riedle; Julia Löhr; Hugo A Katus; Kiril M Stoyanov
Journal:  Clin Res Cardiol       Date:  2019-07-19       Impact factor: 5.460

2.  Acute effects of outdoor air pollution on emergency department visits due to five clinical subtypes of coronary heart diseases in shanghai, china.

Authors:  Juan Xie; Mingzhen He; Weiying Zhu
Journal:  J Epidemiol       Date:  2014-07-05       Impact factor: 3.211

3.  High-Sensitivity Cardiac Troponin Concentrations in Patients with Chest Discomfort: Is It the Heart or the Kidneys As Well?

Authors:  Eline P M Cardinaels; Sibel Altintas; Mathijs O Versteylen; Ivo A Joosen; Laurens-Jan C Jellema; Joachim E Wildberger; Marco Das; Harry J Crijns; Otto Bekers; Marja P van Dieijen-Visser; Bastiaan L Kietselaer; Alma M A Mingels
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

4.  Typical angina is associated with greater coronary endothelial dysfunction but not abnormal vasodilatory reserve.

Authors:  Ahmed AlBadri; Derek Leong; C Noel Bairey Merz; Janet Wei; Eileen M Handberg; Chrisandra L Shufelt; Puja K Mehta; Michael D Nelson; Louise E Thomson; Daniel S Berman; Leslee J Shaw; Galen Cook-Wiens; Carl J Pepine
Journal:  Clin Cardiol       Date:  2017-06-12       Impact factor: 3.287

5.  Pericardial fat and its influence on cardiac diastolic function.

Authors:  Vera H W de Wit-Verheggen; Sibel Altintas; Romy J M Spee; Casper Mihl; Sander M J van Kuijk; Joachim E Wildberger; Vera B Schrauwen-Hinderling; Bas L J H Kietselaer; Tineke van de Weijer
Journal:  Cardiovasc Diabetol       Date:  2020-08-17       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.